ACHV Stock Analysis: Buy, Sell, or Hold?
ACHV - Achieve Life Sciences, Inc.
$4.18
-0.16 (-3.69%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 10, 2026
Smart Money Accumulation
ACHV is down 25.4% this week, but smart money is accumulating calls. Top strike: $5 2026-03-20 with 5,220 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When ACHV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ACHV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ACHV is down 25.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ACHV is down 25.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACHV is currently trading at $4.18, which is considered oversold relative to its 30-day fair value range of $4.56 to $5.57.
Technical Outlook: Technically, ACHV is in a strong uptrend. The price is currently testing key support at $4.17. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.38 (+254.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACHV is in a strong uptrend. The price is currently testing key support at $4.17. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.38 (+254.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$4.56 -
$5.57
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding ACHV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 254.3% below Wall St target ($15.38)
- WARNING: Recommendation downgraded due to -25.4% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.56 -
$5.57
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$4.17
Resistance Level
$6.03
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.67
Wall Street Target
$15.38
(+254.3%)
Last updated: January 31, 2026 1:54 AM ET
Data refreshes hourly during market hours. Next update: 2:54 AM
Data refreshes hourly during market hours. Next update: 2:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACHV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark K Oki
SELL
50060 shares
2025-09-18
Richard Alistair Stewart
SELL
129501 shares
2025-09-18
Cindy Jacobs
SELL
27629 shares
2025-09-04
Featured in Portfolios
ACHV is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced ACHV Option Strategies
Professional options setups generated by AI based on today's ACHV price and gamma walls.
